血友病的结果测量:当前和未来的前景
Silvia Benemei1, Luca Boni2, Giancarlo Castaman3
1Medical Affairs, Pfizer Italia, Rome, Italy.
Expert review of hematology
|June 11, 2024
概括
评估血友病治疗疗效需要不断演变的结果措施. 当前的出血率在先进疗法下变得不那么敏感,因此需要新的工具来全面评估患者.
科学领域:
- 血液学 血液学 血液学
- 临床研究方法论 临床研究方法论
- 治疗评估治疗评估
背景情况:
- 血友病显著影响患者的生活质量和生存率.
- 了解治疗效益对于治疗定位至关重要.
- 适当的结果测量对于评估血友病疗法至关重要.
研究的目的:
- 提供用于血友病临床研究的结果措施的全面审查.
- 批判性地讨论各种结果措施的特点,价值和适用性.
- 强调需要根据血友病治疗的进展调整结果指标的必要性.
主要方法:
- 通过PubMed搜索"血友病和结果"发现的研究的叙述性综述,直到2023年6月.
- 批判性讨论结果措施的特点和适用性.
- 对血友病结果评估中不断变化的趋势的分析.
主要成果:
- 年化出血率仍然是主要终点,但在零出血治疗中可能会失去敏感性.
- 技术进步需要对罕见出血,并发症和复杂的实验室参数进行结果测量.
- 血栓生成试验和患者报告的结果测量结果显示有希望但有局限性.
结论:
- 仍然需要对血友病进行一套明确的研究成果测量.
- 结果措施可能需要根据特定的治疗干预措施进行定制.
- 结果措施的调整是必要的,以准确地反映血友病护理的进展.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Disorders of Hemostasis
837
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Guidelines for Writing Outcome
2.8K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.8K


